Human herpesvirus 6 and multiple sclerosis: Systemic active infections in patients with early disease

Clinical Infectious Diseases

Volumn 31, Issue 4, 2000, Pages 894-903

  Knox, Konstance K ^a   Brewer, Joseph H ^b   Henry, James M ^c   Harrington, Daniel J ^a   Carrigan, Donald R ^a  

^a Institute for Viral Pathogenesis   (United States)

^b Saint Lukes Health System   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; TRANSPLANTATION; VIREMIA; VIRUS CULTURE; VIRUS ENCEPHALITIS;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES; LYMPHOID TISSUE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ORGAN TRANSPLANTATION; VIREMIA;

EID: 0034450722     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318141     Document Type: Article

References (92)

1. Human herpesvirus-6: Neurologic implications of a newly described viral pathogen
2. Human herpesvirus-6 infection in children: A prospective study of complications and reactivations
3. Neuroinvasion and persistence of human herpesvirus-6 in children
4. Human herpesvirus-6 infections in infants admitted to hospital
5. Association of human herpesvirus-6 infection of the central nervous system with recurrence of febrile convulsions
6. Primary human herpesvirus 6 infection is frequently overlooked as a cause of febrile fits in young children
7. Acute disseminated demyelination due to primary human herpesvirus-6 infection
8. Basal ganglia infarction associated with HHV-6 infection
9. Fulminant human herpesvirus six (HHV-6) encephalitis in an HIV infected infant
10. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow transplant recipient
11. Human herpesvirus-6 meningoencephalitis with sequelae
12. Human herpes virus 6 encephalitis after bone marrow transplantation: Successful treatment with ganciclovir
13. Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation
14. Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant
15. Successful treatment of human herpesvirus-6 encephalitis in a bone marrow transplant recipient
16. Human herpesvirus-6 encephalitis after bone marrow transplantation: Magnetic resonance imaging could identify the involved sites of encephalitis
17. Human herpesvirus-6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: Does it have clinical significance?
18. Human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient
19. Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient
20. Chronic myelopathy associated with human herpesvirus-6
21. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS
22. Cellular localization of human herpesvirus-6 in the brains of children with AIDS encephalopathy
23. Human herpesvirus-6 is associated with focal encephalitis
24. Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult
25. The Norton lecture: A review of the oligodendrocyte in the multiple sclerosis lesion
26. Axonal transection in the lesions of multiple sclerosis
27. Plaque associated expression of human herpesvirus-6 in multiple sclerosis
28. Human herpesvirus-6 and multiple sclerosis: Survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction
29. A potential role for human herpesvirus type 6 in nervous system disease
30. Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: A preliminary report
31. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis
32. Inhibition of PCR by aqueous and vitreous fluids
33. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA
34. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis
35. Human herpesvirus six and multiple sclerosis
36. The natural history of multiple sclerosis
37. Identification and characterization of a cDNA derived from multiple splicing that encodes envelope glycoprotein gp105 of human herpesvirus-6
38. Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus-6 and mapping of the neutralizing epitope recognized by monoclonal antibodies
39. Identification of a variant B-specific neutralizing epitope on glycoprotein H of human herpesvirus-6
40. Analysis of a glycoprotein of human herpesvirus 6 (HHV-6) using monoclonal antibodies
41. Progressive immunodeficiency and fatal pneumonitis associated with HHV-6 infection in an infant
42. Active HHV-6 infection in the lymph nodes of HIV infected patients: In vitro evidence that HHV-6 can break HIV latency
43. Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity
44. Human herpesvirus-6 in transplantation: An emerging pathogen
45. Diagnosis of active human herpesvirus six (HHV-6) infections in immunocompromised patients with a rapid shell-vial assay
46. The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution
47. Human herpesvirus-6 in liver transplant recipients: Role in pathogenesis of fungal infections, neurologic complications, and outcome
48. Human herpes virus 6 infection after hematopoietic stem cell transplantation
49. The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: Oligodendrocytes and microglia
50. Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6
51. Distribution of human herpesvirus 6 and varicella-zoster virus in organs of a fatal case with exanthem subitum and varicella
52. HHV-6 and multiple sclerosis
53. Genetics of multiple sclerosis
54. Genetics of multiple sclerosis - How could disease associated HLA types contribute to pathogenesis?
55. Immune response to neutralizing epitope on human cytomegalovirus glycoprotein B in Japanese: Correlation of serologic response with HLA-type
56. Human herpesvirus 6 and human herpesvirus 8 DNA sequences in brains of multiple sclerosis patients, normal adults, and children
57. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients
58. Human herpesvirus 6 is latent in peripheral blood of patients with relapsing remitting multiple sclerosis
59. Human herpesvirus-6 and bone marrow transplantation
60. Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: Random tests and prospective longitudinal studies
61. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals
62. The association of the human herpesvirus 6 and MS
63. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis
64. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction
65. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis
66. Polymerase chain reaction of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis
67. On the role of human herpesvirus 6 in viral latency in nervous tissue and cerebral lymphoma
68. Human herpesvirus 6 infection in normal brain tissue
69. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients
70. Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis
71. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls
72. Persistence of human herpesvirus 6 according to site and variant: Possible greater neurotropism of variant A
73. In vitro suppression of marrow progenitor cell differentiation by human herpesvirus six infection
74. Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)
75. Infection of primary human fetal astrocytes by human herpesvirus 6
76. Difference in permissiveness of human fibroblast cells to variants A and B of human herpesvirus 6
77. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
78. Tumor necrosis factor identified in multiple sclerosis brain
79. Tumor necrosis factor-� messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity
80. Human herpesvirus 6 induces interleukin-1β and tumor necrosis factor �, but not interleukin-6, in peripheral blood mononuclear cell cultures
81. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis: A comparative study
82. Pathogenesis of neuroimmunologic diseases: Experimental models
83. Initiation and regulation of CNS autoimmunity
84. The natural history of multiple sclerosis
85. Prediction of outcome in multiple sclerosis based on multivariate models
86. Recognition of the immunodominat myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients: Identity of key contact residues in the B-cell and T-cell epitopes
87. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis
88. Molecular mimicry in T cell mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
89. Encephalitogenic epitopes of myelin basic protein
90. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis
91. Lymphotropic herpesviruses in allogeneic bone marrow transplantation
92. Acyclovir treatment of relapsing-remitting multiple sclerosis: A randomized, placebo-controlled, double-blind study